90 completed, 17 terminated, 14 unknown, 9 recruiting. 143 Phase 2, 21 Phase 1, 2 Phase 3.
Follow Carmustine: new trials by email Literature Review of Carmustine trials Research Report on Carmustine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tebentafusp-tebn With LDT in Metastatic UM Tebentafusp-Tebn, GM-CSF (Sargramostim), BCNU - Metastatic Uveal Melanoma | Phase 1 / Phase 2 | Recruiting | Thomas Jefferson University | 109 | 2025-10-15 | 2026-07-21 |
| Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment Orelabrutinib, Rituximab (R), BEAM (carmustine (BCNU), etoposide, cytarabine, melphalan) - Mantle Cell Lymphoma (MCL) | Phase 2 | Recruiting | Ruijin Hospital | 45 | 2025-07-01 | 2025-09-30 |
| A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma VI-0609, BiCNU - Lymphoma, Non-Hodgkin Lymphoma | Phase 2 | Recruiting | VIVUS LLC | 49 | 2025-03-12 | 2026-03-27 |
| CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant Thiotepa, Carmustine, Autologous Stem Cell Transplant - Diffuse Large B Cell Lymphoma | Phase 2 | Recruiting | Washington University School of Medicine | 36 | 2025-01-16 | 2026-08-28 |
| Tazemetostat Plus CHOP in 1L T-cell Lymphoma Tazemetostat, Doxorubicin, Vincristine - Lymphoma, Peripheral T Cell Lymphoma | Phase 2 | Withdrawn | Eric Jacobsen, MD | 2024-12-24 | 2026-04-01 | |
| MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma Pembrolizumab, Autologous stem cell transplant, Carmustine - Autologous Stem Cell Transplant, Classic Hodgkin Lymphoma | Phase 2 | Recruiting | Masonic Cancer Center, University of Minnesota | 28 | 2024-12-04 | 2026-09-29 |
| hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) P140K-MGMT, O6-benzylguanine, Photon Based Radiotherapy - Glioblastoma Multiforme, Glioblastoma Multiforme, Adult | Phase 2 | Recruiting | Leland Metheny | 16 | 2023-01-20 | 2026-09-10 |
| Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma Basiliximab, Carmustine, Cytarabine - Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma | Phase 2 | Recruiting | City of Hope Medical Center | 33 | 2021-11-02 | 2025-12-04 |
| Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases Carmustine, Ethiodized Oil, Transarterial Chemoembolization - Metastatic Malignant Neoplasm in the Liver, Metastatic Uveal Melanoma | Phase 2 | Active not recruiting | Thomas Jefferson University | 28 | 2021-09-27 | 2026-05-06 |
| RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide - Primary CNS Lymphoma | Phase 2 | Unknown | National Research Center for Hematology, Russia | 30 | 2021-05-17 | 2022-06-21 |
| A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease Carmustine 7.7Mg Wafer - Brain Tumor - Metastatic | Phase 2 | Recruiting | University of Nebraska | 100 | 2020-11-06 | 2026-04-28 |
| A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma Selinexor, Temozolomide (TMZ), Lomustine (CCNU) - Glioblastoma Multiforme | Phase 1 / Phase 2 | Terminated | Karyopharm Therapeutics Inc | 74 | 2020-06-08 | 2024-12-16 |
| CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma Autologous Hematopoietic Stem Cell Transplantation, Carmustine, Cytarabine - CD19 Positive, Mantle Cell Lymphoma | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2019-10-03 | 2020-01-29 | |
| Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL Carboplatin, Ifosfamide, Etoposide - Diffuse Large B Cell Lymphoma | Phase 2 | Unknown | Swedish Medical Center | 47 | 2019-08-16 | 2022-07-22 |
| Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma Carmustine, Cytarabine, Etoposide - Hematopoietic Cell Transplantation Recipient, Recurrent Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | Completed | Ohio State University Comprehensive Cancer Center | 19 | 2018-09-10 | 2025-05-14 |
| A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion Allopurinol, Carmustine, Etoposide - Multiple Myeloma | Phase 2 | Unknown | Swedish Medical Center | 100 | 2018-09-05 | 2022-06-22 |
| Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects Chidamide - Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma | Phase 2 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 69 | 2018-02-01 | 2022-01-03 |
| Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients Carmustine, Cyclophosphamide, Carboplatin - Triple-Negative Invasive Breast Carcinoma, Residual Tumor | Phase 2 | Unknown | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 20 | 2018-02-01 | 2020-01-14 |
| Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects VBI-1901, Carmustine, Lomustine - Glioblastoma Multiforme | Phase 1 / Phase 2 | Terminated | VBI Vaccines Inc. | 70 | 2017-12-06 | 2026-05-08 |
| Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma Autologous Hematopoietic Stem Cell Transplantation, Carmustine, Cord Blood-derived Expanded Allogeneic Natural Killer Cells - Mantle Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 22 | 2017-10-10 | 2023-02-16 |
Showing 20 of 143. Sign in to see all of them.
Lymphoma (49) · Lymphoma, Non-Hodgkin (39) · Lymphoma, Large B-Cell, Diffuse (34) · Lymphoma, Mantle-Cell (30) · Hodgkin Disease (26) · Lymphoma, Follicular (25) · Glioblastoma (24) · Gliosarcoma (18) · Brain Neoplasms (16) · Burkitt Lymphoma (16) · Central Nervous System Neoplasms (16) · Leukemia, Lymphocytic, Chronic, B-Cell (16) · Lymphoma, Large-Cell, Immunoblastic (16) · Multiple Myeloma (14) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (12)
Memorial Sloan Kettering Cancer Center (9) · M.D. Anderson Cancer Center (8) · University of Maryland, Baltimore (8) · Alliance for Clinical Trials in Oncology (7) · University of Nebraska (7) · Fred Hutchinson Cancer Center (6) · Masonic Cancer Center, University of Minnesota (6) · Stanford University (6) · Duke University (5) · Barbara Ann Karmanos Cancer Institute (3) · Cancer Research UK (3) · Case Comprehensive Cancer Center (3) · City of Hope Medical Center (3) · Washington University School of Medicine (3) · Children's Oncology Group (2)
United States (116) · Germany (7) · Canada (5) · Italy (5) · United Kingdom (5) · France (4) · Netherlands (3) · Australia (2) · China (2) · Puerto Rico (2) · Switzerland (2) · Austria (1) · Belgium (1) · Czechia (1) · Denmark (1)
Aaron P. Rapoport, MD (3) · Barry R. Meisenberg, MD (3) · Daniel J. Weisdorf, MD (3) · Henry S. Friedman, MD (3) · Issa F. Khouri, MD (3) · Craig Moskowitz, MD (2) · Gene David Resnick, MD (2) · Julie M Vose, MD (2) · Laura Johnston (2) · Leona Holmberg (2) · Mary Horowitz, MD (2) · Veronika Bachanova, MD (2) · Wen-Kai Weng (2) · Agnieszka Korfel, MD (1)
PMID 1403051, PMID 14769138, PMID 15073861, PMID 15667956, PMID 16750317, PMID 18723297, PMID 19021050, PMID 19188181, PMID 19204207, PMID 19533025, PMID 19917845, PMID 20063115, PMID 20637881, PMID 20800387, PMID 21073974, PMID 21552302, PMID 21602899, PMID 22102709, PMID 22490331, PMID 23242601, PMID 23834234, PMID 24531550, PMID 25072780, PMID 25105369, PMID 25546364, PMID 27132696, PMID 27297790, PMID 27476790, PMID 28148635, PMID 28199478, PMID 28559537, PMID 28602891, PMID 29054815, PMID 29289757, PMID 29456529, PMID 29476021, PMID 30104718, PMID 30826465, PMID 31371411, PMID 31869413, PMID 32499241, PMID 32971036, PMID 33513372, PMID 33586581, PMID 33783067, PMID 34515338, PMID 37875524, PMID 38271621, PMID 38598710, PMID 38669626
P30CA015704 (4), P30CA043703 (4), P30CA022453 (3), P30CA033572 (3), P30CA016672 (2), P30CA036727 (2), P30CA093373 (2), U01CA062502 (2), U01CA121947 (2), U01HL069294 (2), U10CA031946 (2), U10CA032102 (2), 2009 (1), K23AI052413 (1), P01CA030206 (1)